Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine
Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine
The quality of recovery in patients who were reversed neuromuscular blockade by using
 Sumamadex and Neostigmine in laparoscopic cholecystectomy was compared through the
 QoR(Quality of Recovery)-15 questionnaire.
Quality of Recovery questionnaire includes five details (Emotional status, Physical comfort,
 Physiological support, Physical independece, Pain), and is a proven method of reliability,
 consistency and validity for evaluating recovery from surgery and anesthesia.

 After laparoscopic cholecystectomy, patients experience various discomforts such as pain,
 nausea, vomiting, and placebo due to general anesthesia.

 Neostigmine has side effects such as crampy abdominal pain, nausea and vomiting. In addition,
 residual neuromuscular blockade was higher in neostigmine compared with sugammadex.

 Although sugammadex expected to improve patient's recovery, it is still controversial that
 sugammadex contributes to clinically meaningfull difference compared with neostigmine.

 Therefore, the aim of our study is comparison of quality of recovery through QoR-15
 questionnaire in patients who were reversed neuromuscular blockade by using sugammadex and
 neostigmine in laparoscopic cholecystectomy.
Inclusion Criteria:

 -  patients who underwent laparoscopic cholecystectomy aged 20-70

 Exclusion Criteria:

 -  neuromuscular disease

 -  allergy to rocuronium, sugammadex, neostigmine

 -  cognitive impairment ( disable to answer the questionnaire )

 -  refuse to participate